3SBio Inc - Company Profile
Powered by 
All the data and insights you need on 3SBio Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date 3SBio Inc Strategy Report
- Understand 3SBio Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on 3SBio Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 28 Jul 2022 | 3SBio Enters into Licensing Agreement with Cosmo Pharma | Licensing Agreement |
3SBio Inc
|
Cosmo Pharmaceuticals NV |
| 14 Dec 2021 | Sunshine Guojian Pharma (Shanghai) Exercises Option from Numab Therapeutics | Licensing Agreement |
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
|
Numab Therapeutics AG
|
| 31 Aug 2021 | 3SBio(Sansheng Guojian) and ABM Therapeutics Enter into Co-Development Agreement | Partnership | - |
ABM Therapeutics Inc
3SBio Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer